Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-04-25

Clinical Trial Update: Ductal Lavage in Assessing Women With Early Breast Cancer or at High Risk of Developing Breast Cancer and Who Are Eligible For Tamoxifen Therapy

View source ↗

Summary

A clinical trial investigating ductal lavage in women with early breast cancer or at high risk who are eligible for tamoxifen therapy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tamoxifen (tamoxifen)

Snippet

Sponsor: Northwestern University | Conditions: Breast Cancer | Status: WITHDRAWN